LUIS GONZAGA
PAZ-ARES RODRÍGUEZ
Profesor titular de universidad
Johns Hopkins University
Baltimore, Estados UnidosPublicaciones en colaboración con investigadores/as de Johns Hopkins University (3)
2023
-
Emerging therapies targeting the delta-like ligand 3 (DLL3) in small cell lung cancer
Journal of Hematology and Oncology, Vol. 16, Núm. 1
2015
-
First-in-human dose study of the novel transforming growth factor-β receptor I kinase inhibitor LY2157299 monohydrate in patients with advanced cancer and glioma
Clinical Cancer Research, Vol. 21, Núm. 3, pp. 553-560
-
Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor i kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer
Investigational New Drugs, Vol. 33, Núm. 2, pp. 357-370